Therapeutic management of hyperlipoproteinemia (a)

Cardiovascular disease (CVD) has consistently been the leading cause of death worldwide. Several clinical and epidemiological studies have demonstrated that an elevated plasma concentration of lipoprotein (a) [Lp(a)] is a causative and independent major risk factor for the development of CVD, as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E, Sourlas, Andreas, Mallarkey, Gordon, Silverio, Delia, Ynoa, Domingo Y, Montan, Peter D, Guzman, Eliscer, Garcia, Mario J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752750/
https://www.ncbi.nlm.nih.gov/pubmed/31555339
http://dx.doi.org/10.7573/dic.212609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752750/
https://www.ncbi.nlm.nih.gov/pubmed/31555339
http://dx.doi.org/10.7573/dic.212609

Ejemplares similares